Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Fluorescence Imaging in Primary Liver Cancer Surgery
NCT05160740Recruiting
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- Sep 2021
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Randomised, open-label trial of indocyanine green in hepatocellular carcinoma (HCC), sponsored by Southern Medical University Zhujiang Hospital. Primary endpoint: Disease-Free Survival at 36 months. Started Sep 2021; status: recruiting.
02
Drugs
indocyanine green
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT05160740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05160740.